Works matching IS 10538569 AND DT 2022 AND VI 31 AND IP 4

Results: 14

Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 411, doi. 10.1002/pds.5412
By:
- Tazare, John;
- Wyss, Richard;
- Franklin, Jessica M.;
- Smeeth, Liam;
- Evans, Stephen J. W.;
- Wang, Shirley V.;
- Schneeweiss, Sebastian;
- Douglas, Ian J.;
- Gagne, Joshua J.;
- Williamson, Elizabeth J.
Publication type:
Article
Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 434, doi. 10.1002/pds.5399
By:
- Bettuzzi, Thomas;
- Ingen‐Housz‐Oro, Saskia;
- Maison, Patrick;
- de Prost, Nicolas;
- Wolkenstein, Pierre;
- Lebrun‐Vignes, Bénédicte;
- Sbidian, Emilie
Publication type:
Article
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 424, doi. 10.1002/pds.5403
By:
- Benasseur, Imane;
- Talbot, Denis;
- Durand, Madeleine;
- Holbrook, Anne;
- Matteau, Alexis;
- Potter, Brian J.;
- Renoux, Christel;
- Schnitzer, Mireille E.;
- Tarride, Jean‐Éric;
- Guertin, Jason R.
Publication type:
Article
Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 442, doi. 10.1002/pds.5402
By:
- Mao, Jialin;
- Sedrakyan, Art;
- Sun, Tianyi;
- Guiahi, Maryam;
- Chudnoff, Scott;
- Kinard, Madris;
- Johnson, Stephen B.
Publication type:
Article
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 476, doi. 10.1002/pds.5401
By:
- Kluberg, Sheryl A.;
- Hou, Laura;
- Dutcher, Sarah K.;
- Billings, Monisha;
- Kit, Brian;
- Toh, Sengwee;
- Dublin, Sascha;
- Haynes, Kevin;
- Kline, Annemarie;
- Maiyani, Mahesh;
- Pawloski, Pamala A.;
- Watson, Eric S.;
- Cocoros, Noelle M.
Publication type:
Article
Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 2019.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 481, doi. 10.1002/pds.5411
By:
- Duchesneau, Emilie D.;
- Kinlaw, Alan C.;
- Jonsson Funk, Michele;
- Pate, Virginia;
- Lund, Jennifer L.
Publication type:
Article
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 404, doi. 10.1002/pds.5410
By:
- Madsen, Jeppe Ekstrand Halkjær;
- Hallas, Jesper;
- Delvin, Thomas;
- Scheike, Thomas;
- Pipper, Christian
Publication type:
Article
Use of negative control outcomes to assess the comparability of patients initiating lipid‐lowering therapies.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 383, doi. 10.1002/pds.5396
By:
- Levintow, Sara N.;
- Orroth, Kate K.;
- Breskin, Alexander;
- Park, Andrew S.;
- Flores‐Arredondo, Jose H.;
- Dluzniewski, Paul;
- Navar, Ann Marie;
- Sørensen, Henrik T.;
- Brookhart, M. Alan
Publication type:
Article
Validity of self‐reports of medication treatment of depression in general population surveys.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 461, doi. 10.1002/pds.5400
By:
- Mojtabai, Ramin;
- Amin‐Esmaeili, Masoumeh
Publication type:
Article
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 467, doi. 10.1002/pds.5398
By:
- Paik, Julie M.;
- Patorno, Elisabetta;
- Zhuo, Min;
- Bessette, Lily G.;
- York, Cassandra;
- Gautam, Nileesa;
- Kim, Dae Hyun;
- Kim, Seoyoung C.
Publication type:
Article
Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 393, doi. 10.1002/pds.5391
By:
- Ellis, Darcy E.;
- Hubbard, Rebecca A.;
- Willis, Allison W.;
- Zuppa, Athena F.;
- Zaoutis, Theoklis E.;
- Hennessy, Sean
Publication type:
Article
Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 452, doi. 10.1002/pds.5386
By:
- Yamana, Hayato;
- Tsuchiya, Asuka;
- Horiguchi, Hiromasa;
- Morita, Shigeki;
- Kuroki, Tamotsu;
- Nakai, Kunio;
- Nishimura, Hideo;
- Jo, Taisuke;
- Fushimi, Kiyohide;
- Yasunaga, Hideo
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 488, doi. 10.1002/pds.5274
Publication type:
Article
Issue Information.
Published in:
Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 1, doi. 10.1002/pds.5498
Publication type:
Article